
Please try another search
Koa Shoji Holdings Co.,Ltd., through its subsidiaries, imports and sells active pharmaceutical ingredients (APIs) in Japan. The company is involved in the manufacture and marketing of OTC drugs and health foods; primarily various vitamins; and manufacture and sale of generic APIs and drugs, as well as pharmaceuticals comprising injections. It also engages in contract manufacturing of pharmaceuticals; packaging of pharmaceutical products; and purchase and sale of pharmaceuticals. Koa Shoji Holdings Co.,Ltd. was founded in 1991 and is headquartered in Yokohama, Japan.
Name | Age | Since | Title |
---|---|---|---|
Toshiyuki Shuto | 75 | - | President, CEO & Chairman of the Board of Directors |
Toshinori Koyama | 74 | 2015 | Executive MD of Sales & Director |
Shinro Sadanobu | 70 | - | Director |
Miyoko Komatsu | 60 | 2016 | Director of Finance & Accounting & Director |
Teruyuki Tanaka | 74 | 2018 | Director of Business Development & Corporate Planning & Director |
Toshihiro Hirono | 75 | 2015 | MD of Production & Director |
Ritsuko Ohtsuka | 46 | 2015 | Executive VP, MD, Sustainability Officer & Director |
Yoshitaka Hirao | 72 | 2017 | Independent Outside Director |
Hiroshi Kinoshita | 57 | 2022 | Independent Outside Director |
Kyoko Hayashi | 59 | 2023 | Independent Outside Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review